| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/19/2004 | WO2004037784A3 Pyrrolidones with anti-hiv activity |
| 08/19/2004 | WO2004009036A3 Compounds compositions and methods |
| 08/19/2004 | WO2004002409A3 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/19/2004 | WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 08/19/2004 | WO2003092688A3 Heterocyclic derivatives as opioid modulators |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 08/19/2004 | US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 08/19/2004 | US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes |
| 08/19/2004 | US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162313 Heterocyclic derivatives |
| 08/19/2004 | US20040162303 4-aminopyrimidine-5-one derivatives |
| 08/19/2004 | US20040162295 Pharmaceutical compound |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162285 Anti-infective agents |
| 08/19/2004 | US20040162282 Substituted piperazines |
| 08/19/2004 | US20040162278 Triazole compounds useful in therapy |
| 08/19/2004 | US20040162276 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology |
| 08/19/2004 | US20040161805 Cardiovascular safety assay |
| 08/19/2004 | US20040161441 Containing permethrin, imidacloprid and n-methylpyrrolidone; killing ticks and fleas; skin friendly, low toxicity; storage stability |
| 08/19/2004 | DE10304870A1 Triazolverbindungen und ihre therapeutische Verwendung Triazole compounds and their therapeutic use |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2515119A1 Pyrazole derivative |
| 08/19/2004 | CA2515116A1 Amino-1,3,5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators |
| 08/19/2004 | CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
| 08/19/2004 | CA2513915A1 New arylpiperazinyl compounds |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | CA2512915A1 4-aminopyrimidine-5-one |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/18/2004 | EP1446400A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents |
| 08/18/2004 | EP1446224A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1242405B1 Method for producing 4-(heteroaryl-methyl)-1(2h)-phthalazinones |
| 08/18/2004 | EP1222173B1 Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP0876345B1 Heterocyclic compounds as h+-atpases |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | EP0619813B1 Linked cyclic polyamines with activity against hiv |
| 08/18/2004 | CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/18/2004 | CN1522251A Azole compounds, process for preparation of the same and use thereof |
| 08/18/2004 | CN1522250A Cyclic diamine compound having five-membered cyclic group |
| 08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1521166A Process for preparing 1 -(3 -hydroxymethyl pyridyl-2) -2-phenyl-4- methyl piperazine |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/18/2004 | CN1162424C Quinoline-4-yl derivative II |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777438 Inhibitors of farnesyl protein transferase |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777431 Non-convalent thrombin inhibitors |
| 08/17/2004 | US6777430 Phenylsulphonyl derivatives as 5-HT receptor ligands |
| 08/17/2004 | US6777428 Inhibit peptide extravasation due to stimulation of the trigeminal ganglia, and are therefore useful for the treatment of migraine and associated disorders |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777426 Imidazole and imidazoline derivatives and uses thereof |
| 08/17/2004 | US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering |
| 08/17/2004 | US6777422 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 08/17/2004 | US6777420 Heterocyclic antibacterial compounds |
| 08/17/2004 | US6777417 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors |
| 08/17/2004 | US6777413 For therapy and prophylaxis of conditions in mammals characterized by undesired thrombosis |
| 08/17/2004 | US6777412 Fungicides |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/12/2004 | WO2004067703A2 5ht7 antagonists and inverse agonists |
| 08/12/2004 | WO2004067675A2 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 08/12/2004 | WO2004067673A1 Electrochromic compounds |
| 08/12/2004 | WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors |
| 08/12/2004 | WO2004067528A1 Cyano anthranilamide insecticides |
| 08/12/2004 | WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/12/2004 | WO2004067513A1 Antagonists for alpha-2 adrenoceptors |
| 08/12/2004 | WO2004067510A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 08/12/2004 | WO2004066999A1 Compositions containing 2, 2’ -methylenebisbenzimidazole derivatives for treating ischemia-related neuronal damage |
| 08/12/2004 | WO2004066996A1 NF-kB INHIBITORS AND USES THEREOF |
| 08/12/2004 | WO2004066952A2 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| 08/12/2004 | WO2004066951A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 08/12/2004 | WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2004 | WO2004056779A3 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 08/12/2004 | WO2004056770A3 Piperidine derivatives useful as ccr5 antagonists |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/12/2004 | WO2004046118A3 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders |
| 08/12/2004 | WO2004032908A3 Method of inhibiting angiogenesis |